Given the well-described pro-tumorigenic activities of estrogen and the acquisition of an invasive and migratory phenotype in the ovarian cancer model’s progesterone activation of DREAM, we examined our estrogen-treated cell lines and patients to determine if the induction of quiescence was similarly linked to pro-tumorigenic consequences. The gene discussed is KCNIP3; the disease is ovarian cancer.